About HS Code 300630
This category covers pharmaceutical goods such as opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient. These products are indispensable for modern diagnostic medicine, enabling clear visualization of internal structures and the detection of various diseases. The international trade involves specialized pharmaceutical companies, supplying hospitals, imaging centers, and diagnostic laboratories worldwide. Strict regulatory oversight ensures the safety and efficacy of these agents, which are directly introduced into the human body. Key considerations include patient safety profiles, imaging clarity, and the development of new, less invasive diagnostic tools. The market is driven by the increasing demand for accurate and early disease detection across a wide range of medical specialties.
Products Under This Code
Iodine-based contrast media, Gadolinium-based contrast agents (for MRI), Barium sulfate preparations, Technetium-99m diagnostic agents, Glucose solutions for PET scans, Diagnostic dyes (e.g., Methylene Blue), Indocyanine green for angiography
Real World Examples
Omnipaque (iohexol), Magnevist (gadopentetate dimeglumine), E-Z-HD (barium sulfate), Cardiolite (technetium sestamibi), Visipaque (iodixanol)
Common Misclassification
Can be confused with 3822 (diagnostic or laboratory reagents not administered to patients) if the distinction of "administered to the patient" is overlooked, or 2844 for radioactive elements in bulk.
Products Classified Under 3006.30
Industry
This code belongs to the Chemicals industry.
Trade Overview
The USA, Germany, and Japan are major importers due to advanced healthcare infrastructure, while the USA, Germany, and Ireland are leading exporters of these specialized diagnostic pharmaceuticals.
Frequently Asked Questions
What is HS code 300630?
HS code 300630 covers: Pharmaceutical goods; opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient. This category covers pharmaceutical goods such as opacifying preparations for X-ray examinations and diagnostic reagents designed to be administered to the patient. These products are indispensable for modern diagnostic medicine, enabling clear visualization of internal structures and the detection of various diseases. The international trade involves specialized pharmaceutical companies, supplying hospitals, imaging centers, and diagnostic laboratories worldwide. Strict regulatory oversight ensures the safety and efficacy of these agents, which are directly introduced into the human body. Key considerations include patient safety profiles, imaging clarity, and the development of new, less invasive diagnostic tools. The market is driven by the increasing demand for accurate and early disease detection across a wide range of medical specialties.
What products fall under HS code 300630?
Iodine-based contrast media, Gadolinium-based contrast agents (for MRI), Barium sulfate preparations, Technetium-99m diagnostic agents, Glucose solutions for PET scans, Diagnostic dyes (e.g., Methylene Blue), Indocyanine green for angiography
What are common misclassifications for HS code 300630?
Can be confused with 3822 (diagnostic or laboratory reagents not administered to patients) if the distinction of "administered to the patient" is overlooked, or 2844 for radioactive elements in bulk.
How is HS code 300630 structured?
HS code 300630 is a 6-digit subheading under the Harmonized System. The first 2 digits (30) identify the chapter, digits 3-4 (06) identify the heading, and digits 5-6 (30) specify the subheading. This code is standardized globally by the World Customs Organization.